Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

Clinical trial NCT00432627 · COMPLETED

Trial details

NCT number: NCT00432627
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2006-12-01
Primary completion: 2010-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.